Xuebin Ji

777 total citations
20 papers, 584 citations indexed

About

Xuebin Ji is a scholar working on Hematology, Pathology and Forensic Medicine and Immunology and Allergy. According to data from OpenAlex, Xuebin Ji has authored 20 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Pathology and Forensic Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Xuebin Ji's work include Platelet Disorders and Treatments (17 papers), Blood groups and transfusion (11 papers) and Autoimmune Bullous Skin Diseases (7 papers). Xuebin Ji is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Blood groups and transfusion (11 papers) and Autoimmune Bullous Skin Diseases (7 papers). Xuebin Ji collaborates with scholars based in China, Thailand and United States. Xuebin Ji's co-authors include Ming Hou, Jun Peng, Ping Qin, Ping Zhang, Maohong Zhang, Chunqing Zhang, Xueyong Wang, Yan Shi, Xiaojuan Zhu and Ning‐ning Shan and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Journal of Hematology & Oncology.

In The Last Decade

Xuebin Ji

20 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuebin Ji China 11 436 141 126 97 54 20 584
Ping Qin China 17 648 1.5× 216 1.5× 168 1.3× 144 1.5× 84 1.6× 45 832
Nora P. Goette Argentina 14 334 0.8× 38 0.3× 62 0.5× 194 2.0× 27 0.5× 30 485
Chul‐Soo Cho South Korea 12 154 0.4× 53 0.4× 227 1.8× 40 0.4× 28 0.5× 19 602
Ferdinando Porretto Italy 11 177 0.4× 73 0.5× 97 0.8× 129 1.3× 19 0.4× 24 443
Toshiaki Shirai Japan 15 254 0.6× 16 0.1× 150 1.2× 71 0.7× 33 0.6× 28 685
I Marschitz Austria 12 101 0.2× 77 0.5× 250 2.0× 110 1.1× 10 0.2× 17 616
Marlyse A. Debrincat Australia 10 296 0.7× 17 0.1× 134 1.1× 90 0.9× 13 0.2× 12 557
Martin J. Auger United Kingdom 10 213 0.5× 66 0.5× 77 0.6× 72 0.7× 8 0.1× 17 470
George Tsirakis Greece 17 386 0.9× 43 0.3× 157 1.2× 85 0.9× 21 0.4× 43 628
G. Laurent France 11 122 0.3× 53 0.4× 35 0.3× 28 0.3× 14 0.3× 17 349

Countries citing papers authored by Xuebin Ji

Since Specialization
Citations

This map shows the geographic impact of Xuebin Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebin Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebin Ji more than expected).

Fields of papers citing papers by Xuebin Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebin Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebin Ji. The network helps show where Xuebin Ji may publish in the future.

Co-authorship network of co-authors of Xuebin Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebin Ji. A scholar is included among the top collaborators of Xuebin Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebin Ji. Xuebin Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yafei, Zhenyu Yan, Yajing Zhao, et al.. (2024). Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review. Diagnostic Pathology. 19(1). 122–122. 1 indexed citations
2.
Wang, Yun, Lei Sheng, Fengjiao Han, et al.. (2022). Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: a systematic review and network meta-analysis. EClinicalMedicine. 56. 101777–101777. 12 indexed citations
3.
Ji, Xuebin, Jing Lin, Rui Zhang, et al.. (2022). Influence Law of Foundation Pit Excavation on Stress of Surrounding Tunnel Bolt. Applied Sciences. 12(22). 11479–11479. 3 indexed citations
4.
Zhao, Yajing, Pengcheng Xu, Li Guo, et al.. (2021). Tumor Necrosis Factor-α Blockade Corrects Monocyte/Macrophage Imbalance in Primary Immune Thrombocytopenia. Thrombosis and Haemostasis. 121(6). 767–781. 20 indexed citations
5.
Yu, Tianshu, Haoyi Wang, Yajing Zhao, et al.. (2021). Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood Advances. 5(20). 4087–4101. 25 indexed citations
6.
Zhao, Yajing, Xiaofei Ni, Pengcheng Xu, et al.. (2019). Interleukin-37 reduces inflammation and impairs phagocytosis of platelets in immune thrombocytopenia (ITP). Cytokine. 125. 154853–154853. 15 indexed citations
7.
Wei, Yu, Xuebin Ji, Yawen Wang, et al.. (2015). High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 127(3). 296–302. 145 indexed citations
8.
Zhang, Chunmei, et al.. (2015). Biomarkers for immune thrombocytopenia. Biomarker Research. 3(1). 19–19. 8 indexed citations
9.
Liu, Qinghong, Chunmei Zhang, Yongyu Shi, et al.. (2015). Study of a humanized inhibitory anti-platelet glycoprotein VI phage antibody from a phage antibody library. Hematology. 21(1). 60–67. 3 indexed citations
10.
Ji, Xuebin, Ping Zhang, Jun Peng, & Ming Hou. (2014). T cell immune abnormalities in immune thrombocytopenia. Journal of Hematology & Oncology. 7(1). 72–72. 65 indexed citations
11.
12.
Ji, Xuebin & Ming Hou. (2011). Novel agents for anti-platelet therapy. Journal of Hematology & Oncology. 4(1). 44–44. 31 indexed citations
13.
Liu, Xinguang, Jinlin Li, Ping Qin, et al.. (2011). Determination of platelet-bound glycoprotein-specific autoantibodies by flow cytometric immunobead assay in primary immune thrombocytopenia. European Journal Of Haematology. 86(4). 339–346. 5 indexed citations
14.
Shan, Ning‐ning, Xuebin Ji, Xin Wang, et al.. (2011). In vitro recovery of Th1/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa/Fc. Thrombosis Research. 128(6). e119–e124. 17 indexed citations
15.
Wang, Chunyan, Xiaojuan Zhu, Ming Hou, et al.. (2010). [Effect of high-dose dexamethasone on BAFF and Tregs in patients with immune thrombocytopenic purpura.].. PubMed. 31(3). 164–7. 1 indexed citations
16.
Zhu, Xiaojuan, Yan Shi, Jun Peng, et al.. (2009). The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood. 114(26). 5362–5367. 78 indexed citations
17.
Zhang, Aijun, Yanyan Qu, Baojun Zhang, et al.. (2007). The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases. Journal of Molecular Medicine. 85(11). 1263–1270. 26 indexed citations
18.
Hou, Ming, Jun Peng, Yuanyuan Zhu, et al.. (2006). Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments. Blood Coagulation & Fibrinolysis. 17(5). 403–407. 4 indexed citations
19.
Hou, Ming, Jun Peng, Yan Shi, et al.. (2003). Mycophenolate mofetil (MMF) for the treatment of steroid‐resistant idiopathic thrombocytopenic purpura. European Journal Of Haematology. 70(6). 353–357. 113 indexed citations
20.
Hou, Ming, Lu Lu, Yan Shi, et al.. (2003). Both splenic CD5+ B and CD5− B cells produce platelet glycoprotein-specific autoantibodies in chronic ITP. Thrombosis Research. 110(1). 1–5. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Qin Breakdown of academic impact, for papers by Nora P. Goette Breakdown of academic impact, for papers by Chul‐Soo Cho Breakdown of academic impact, for papers by Ferdinando Porretto Breakdown of academic impact, for papers by Toshiaki Shirai Breakdown of academic impact, for papers by I Marschitz Breakdown of academic impact, for papers by Marlyse A. Debrincat Breakdown of academic impact, for papers by Martin J. Auger Breakdown of academic impact, for papers by George Tsirakis Breakdown of academic impact, for papers by G. Laurent
Rankless by CCL
2026